secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001493152-24-009684
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon CEO Corinne Le Goff resigns; Executive Chairman Tardugno assumes interim leadership
--------------------------------------------------------------------------------

- Dr. Corinne Le Goff resigned as President, CEO, and Board member, effective March 15, 2024, to pursue another opportunity.
- Resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Executive Chairman Michael H. Tardugno (former CEO) will lead day-to-day operations until a successor is named.
- Active CEO search is underway; development strategy and key program milestones remain unchanged.
- Milestones: Phase 1 trial of IMNN-101 (COVID-19 booster) prep ongoing; OVATION 2 topline data for IMNN-001 expected summer 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315224009684/0001493152-24-009684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315224009684/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer